Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Meclizine |
| Synonyms | |
| Therapy Description |
Meclizine is a antagonist of the histidine receptor (H1) that also interferes with cellular respiration, potentially resulting in decreased cell viability (PMID: 20160716). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Meclizine | Ancolan | Meclizine is a antagonist of the histidine receptor (H1) that also interferes with cellular respiration, potentially resulting in decreased cell viability (PMID: 20160716). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03253289 | Phase I | Meclizine | Meclizine for Hepatocellular Carcinoma (OPTIM) | Completed | USA | 0 |